15/11/2025
The antioxidant, anticonvulsant, analgesic, and anti-inflammatory activity of coriander EO were evaluated in preclinical models. The EO displayed good antioxidant activity (ABTS assay), which significantly exceeded isolated linalool. Coriander EO also exhibited significant anticonvulsant effects after being challenged by a seizure-inducing substance when ingested. The EO reduced seizure frequency by 43%. The same amount of coriander EO remarkably reduced pain (analgesic), with only slightly lower efficacy compared to tramadol. Lastly, the EO demonstrated the ability to reduce inflammation and pro-inflammatory cytokines (IL-1β and IL-6), which was comparable to ibuprofen. Molecular docking revealed linalool had a moderate binding affinity to COX-1 and COX-2, sharing some key qualities with reference drugs. Based on its favorable safety profile and demonstrated therapeutic effects, the researchers concluded that coriander EO is a promising natural solutions for seizures, pain, and inflammation.
https://pubmed.ncbi.nlm.nih.gov/41113205/